Effects of BRAF and ERK inhibition on papillary and anaplastic thyroid cancer. Effects of BRAF and ERK inhibition on papillary and anaplastic thyroid cancer
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA913907
下载链接
链接失效反馈官方服务：
资源简介：
To investigate the effects of combined BRAF inhibition (dabrafenib) and ERK inhibition (ulixertinib) on papillary and anaplastic thyroid cancer transcriptional reprogramming Overall design: Comparative gene expression profiling analysis of RNA-sequencing data for CUTC5 and CUTC60 cells treated with vehicle, dabrafenib, ulixertinib, or the combination
创建时间：
2022-12-19
